Pharmaceutical and Diagnostic Company Contracts...
The CEL contracts with pharmaceutical companies to evaluate the efficacy and safety of
drugs that target endocrine based diseases. These studies have largely focused on steroid
biochemistry and the determination of blood and urine estradiol and estrone levels using
ultra-sensitive methods to detect the suppressed, postmenopausal levels. Several Phase I
and Phase III studies have been carried out with companies such as Ciba Geigy, US
Bioscience, Zeneca, Merrel Dow and Pharmacia. These projects examined the efficacy and
potency of aromatase inhibitors used for second line therapy of breast cancer. The CEL
staff is experienced in all aspects of clinical trial hormone analysis and is able to
customize its support for each individual study. Please learn more about some specific
drug studies that the CEL was involved in by visiting the Projects/Contracts section. The
CEL also functions as a trial site for Pre-FDA approval evaluation of instruments and
reagents for diagnostic companies. Abbott Laboratories, Dupont, Behring Diagnostics,
Johnson & Johnson Clinical Diagnostics, INCstar and Hybritech are a few companies that
have contracted testing and evaluation support from the CEL.
Return to Services page.
The Core Endocrine Laboratory Web site is maintained by Christopher Hamilton 
